María Dolores
Boyano López
Hospital Universitario de Basurto
Bilbao, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Basurto (13)
2023
-
A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma
Life, Vol. 13, Núm. 1
-
Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients
Cancers, Vol. 15, Núm. 7
-
Melanoma and Nevi Subtype Histopathological Characterization with Optical Coherence Tomography
Life, Vol. 13, Núm. 3
-
Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression
Scientific Reports, Vol. 13, Núm. 1
2022
-
Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis
Life, Vol. 12, Núm. 12
2020
-
BRAF V600E mutational load as a prognosis biomarker in malignant melanoma
PLoS ONE, Vol. 15, Núm. 3
-
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study
Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718
2014
2011
-
A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene
PLoS ONE, Vol. 6, Núm. 4
-
Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms
Apoptosis, Vol. 16, Núm. 12, pp. 1253-1267
2010
-
The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79
Human Heredity, Vol. 69, Núm. 1, pp. 34-44
2009
-
Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma
British Journal of Dermatology, Vol. 160, Núm. 3, pp. 519-526